Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-013643
Filing Date
2025-02-14
Accepted
2025-02-14 10:50:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7509
2 EXHIBIT A tm255635d1_ex99-a.htm EX-99.A 3865
  Complete submission text file 0001104659-25-013643.txt   13203
Mailing Address 1010 SHERBROOKE ST., WEST SUITE 1610 MONTREAL A8 H3A 2R7
Business Address 1010 SHERBROOKE ST., WEST SUITE 1610 MONTREAL A8 H3A 2R7 514 849 8777
SECTORAL ASSET MANAGEMENT INC (Filed by) CIK: 0001274413 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8
Type: SCHEDULE 13G/A

Mailing Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Subject) CIK: 0001855175 (see all company filings)

EIN.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94496 | Film No.: 25624768
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)